BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

05 Aug 2024 09:45:07 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

10 Jul 2024 12:00:38 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

05 Jul 2024 11:13:25 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

21 Jun 2024 09:54:32 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

18 Jun 2024 15:00:15 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

23 May 2024 10:27:03 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

22 May 2024 11:13:46 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

21 May 2024 09:50:48 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

20 May 2024 13:44:10 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

17 May 2024 09:47:43 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

16 May 2024 15:18:13 By NetDania Notify

NetDania - New 12 months Low: BOLT BIOTHERAPEUTICS INC. - COMMON STOCK

15 May 2024 10:16:14 By NetDania Notify

Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team

14 May 2024 16:05:00 By Nasdaq GlobeNewswire

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

21 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

27 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

05 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

09 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference

07 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress

23 Oct 2023 10:30:00 By Nasdaq GlobeNewswire

Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual Meeting

18 Oct 2023 07:00:00 By Nasdaq GlobeNewswire